Authors


Thomas DeGraba, MD

Latest:

An Integrated Practice Unit Tool for the Military Health System

Researchers developed and tested an assessment tool to measure coordinated care for traumatic brain injury against the criteria of an integrated practice unit.


Jenny Tse, MS

Latest:

Real-world HIV Diagnostic Testing Patterns in the United States

This retrospective study evaluated real-world implementation of the updated CDC HIV algorithm in a large US laboratory.


Patrick Campbell

Latest:

FDA Approves Acoramidis for ATTR-CM

With approval, acoramaidis (Attruby; BridgeBio Pharma) becomes the first agent with a label specifying near-complete stabilization of transthyretin (TTR).


Sabrina Serani

Latest:

Elraglusib Granted FDA Orphan Drug Status in Soft Tissue Sarcoma

The FDA granted orphan drug designation for elraglusib, a novel drug for treating advanced soft tissue sarcoma.


Andrew J. Cooper, MSc

Latest:

Treatment Modification After Initiating Second-Line Medication for Type 2 Diabetes

Among adults with type 2 diabetes who started noninsulin second-line therapy, most modified treatment within 1 year. Discontinuation was by far the most common modification.



Robert Holleman, MPH

Latest:

Agreement Among Measures Examining Low-Value Imaging for Low Back Pain

This study demonstrates the need for additional consensus surrounding how to translate guideline recommendations to administrative measures assessing imaging overuse for acute low back pain.



Alexander Gordee, MA

Latest:

Systemic Treatments for Advanced Prostate Cancer: Relationship Between Health Insurance Plan and Treatment Costs

The authors examine how insurer and patient out-of-pocket payments for advanced prostate cancer differ by drug and health plan type and describe the relationship between these payments and utilization.


Phoebe Wright, PharmD, MSc

Latest:

Health Care Resource Utilization, Quality Metrics, and Costs of Bladder Cancer Within the Oncology Care Model

Spending on novel therapies in high-risk bladder cancer had minimal impact on Oncology Care Model payments to practices, according to this cohort study and an average performance estimation.


Vinay K. Rathi, MD, MBA

Latest:

Privately Negotiated Facility Fees at Ambulatory Surgery Centers and Hospitals

Private negotiated facility fees at hospitals are on average double the ambulatory surgery center facility fees for common outpatient procedures.


Xiao Wang, PhD

Latest:

Timely Preterm-Birth Prediction Among Pregnant Women in Medicaid Without Preterm-Birth History

A novel prediction model is developed that accurately predicts preterm birth in a timely manner among pregnant women in Medicaid without preterm-birth history.



Kao-Ping Chua, MD, PhD

Latest:

TCD Screening and Spending Among Children With Sickle Cell Anemia

A substantial proportion of families of privately insured children with sickle cell anemia pay more than $100 for essential stroke screenings, a high-value service.


Julia Jaschke, MSc

Latest:

Cost-effectiveness of Case Management: A Systematic Review

This systematic review found that studies of case management interventions have adequate quality and, in many cases, show cost-effective or even cost-saving results.


Fred Trotter

Latest:

Better Data Is Needed to Tackle Health Equity

The US federal government is finally updating its standards for reporting data on race and ethnicity – and it’s an urgently needed chance to enable a national overview of crucial data on health inequities


Amy Russell, MD

Latest:

Exploring Patient Spending in an ACO-Sponsored Care Management Program: A Case Study

The authors’ multidisciplinary care management program shows promise, as the reduction in per-patient per-month spending was $116. However, these financial benefits took time to materialize.


Nipun Atreja, PhD

Latest:

Journey to Anticoagulant Access Following Payer Rejection of Apixaban

Formulary restrictions can create treatment barriers for patients with atrial fibrillation, including unnecessary delays in treatment and prescription abandonment, with vulnerable populations at greater risk.


Matthew L. Mizel, PhD, MSW

Latest:

Sex Differences in Medicare Beneficiaries’ Experiences by Low-Income Status

Only low-income male Medicare beneficiaries had worse patient experience than their female counterparts. The authors discuss opportunities to improve experiences for all patients.


Kimberly Hartsfield

Latest:

Medicaid Redeterminations Create New Financial Challenges for Hospitals

Hospitals and health systems have been operating in the most challenging financial environment in history, and now they face another looming headwind—the impact of Medicaid redeterminations.


Scott Soefje, PharmD, MBA, BCOP, FCCP, FHOPA

Latest:

Building Better Collaboration: Reducing Care Delays in Managing mCRC

Experts discuss proactive steps health care teams, including pharmacists, can take to minimize delays and overcome payer-related barriers when prescribing third-line therapies for metastatic colorectal cancer (mCRC) and how collaboration between health care teams, payers, and manufacturers can be improved to reduce care delays.


Anne Dunne, RN-BC, MBA

Latest:

COVID-19 and Clinic Workflow Optimization Using Lean Six Sigma

The authors report an approach of outpatient clinic workflow reorganization utilizing simple, inexpensive measures to improve patient engagement and experience in addition to providing a safe setting for patients for clinic visits in the wake of COVID-19.


Greg Trimble, MD

Latest:

Service Line Care Delivery Model for COVID-19 Patient-Centric Care

The authors provide steps hospitals can take to align their care delivery model to effectively meet the demands of a public health crisis such as the current pandemic.


Peter Cram, MD, MBA

Latest:

Availability of Prices for Shoppable Services on Hospital Internet Sites

Only 60% of hospitals display their cash prices and 5% display their minimum negotiated charges on their public websites; many hospitals are in violation of new federal legislation.


Brent P. Forester, MD, MSc

Latest:

The Essential Role of Population Health During and Beyond COVID-19

The authors detail how population health management enables health systems to promote public health, strengthen health system resiliency, and support financial recovery during and beyond coronavirus disease 2019 (COVID-19).


Sunita Thapa, MPH

Latest:

Risk Adjusting for Medicaid Participation in Medicare Advantage

When comparing risk-adjustment approaches based on Medicaid status of Medicare beneficiaries, this analysis found that predicted spending levels varied depending on states’ Medicaid eligibility criteria.


Darin Okuda, MD

Latest:

Future of MS Management

Key opinion leaders in MS provide closing thoughts on the future of MS treatment including digital therapeutics, new generics, and pipeline drugs on the horizon.


JoAnn V. Pinkerton, MD, FACOG, MSCP

Latest:

Closing Thoughts: Evolving Treatment Paradigms in Menopause Management

Panelists express their gratitude for the informative discussion and share their final thoughts on the evolving landscape of menopause management and the potential impact of new therapies on improving patient outcomes.


Fei Teng, MS

Latest:

Continuously Updated Forecasting of SARS-CoV-2 in a Regional Health System

This study presents a methodology for forecasting demand of COVID-19 on health resources in an integrated health system.


Daniel Weisdorf, MD

Latest:

Provider Barriers in Uptake of Biosimilars: Case Study on Filgrastim

Previous studies have found modest uptake of biosimilars in both commercial and Medicare populations. This study finds that the uptake varies between the rural and urban provider settings.

AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo